Follow on Twitter   ·    Follow on LinkedIn   ·   Imprint

PRESENTATIONS

 

 Day 2 – Monday, 17.02.2020 (click to enlarge)

 

 

 

 

 
 

08:00 – 08:15

CCVM Welcome

C. Hengstenberg, G. Laufer

   
 

08:15 – 08:45

Keynote Lecture: Cardiovascular Medicine – A plea for curative medicine

A. Haverich

 

 

 

 

 
 

09:00 – 09:10

Case presentations

C. Nitsche, P. Werner

   
 

09:10 – 12:00

Live case I: Aortic Valve – TAVI (Interventional)

C. Hengstenberg, G. Goliasch

   
 

09:10 – 12:00

Live case II: Aortic Valve – TAVI (RAM or Homograft)

M. Andreas, A. Haverich

   
 

09:20 – 09:30

Developments in cerebral embolic protection

G. Weisz

   
 
 

09:30 – 09:40

Developmens in SAVR: The Ozaki procedure

M. Krane

   

 

10:30 – 10:35

Sapien3 / ultra

W.-K. Kim

   

 

10:35 – 10:40

Evolute R / pro

R. K. Binder

   
 

10:40 – 10:45

Acurate neo

O. Husser

   

 

10:45 – 10:50

Portico

A. Geppert

   

 

 

10:50 – 10:55

Our experience with Myval THV

D. Jagielak

   

 

10:55 – 11:05

The right valve for the right patient – between economics and data

A. Cribier

   

 

11:05 – 11:45

Live case III: Aortic Valve – TAVI (interventional)

C. Hengstenberg

   

 

11:45 – 12:00

TAVI in low risk patients – ready for prime time?

S. Windecker

   

 

12:00 – 12:15

SAVR in 2020 – still the gold standard?

G. Laufer

   

 

 

12:15 – 12:30

The HeartTeam on Stage: Low risk TAVI – blessing or curse

A. Haverich, A. Cribier, G. Weisz, G. Dangas, T. Schmitz

 

 

 

 

 

12:45 – 13:05

TripClip – Experience

A. Zirlik

   
 
 

13:05 – 13:25

MitraClip – Experience

M. Andreas

   
 
 

13:25 – 13:45

Tendyne – Update & Outlook

A. Zierer

 

 

 

 

 
 

14:15 – 14:25

Case presentations

P. Bartko, M. Mach

   

 

14:25 – 15:00

Live case IV: Tricuspid Valve (Interventional)

J. Mascherbauer, J. Hausleiter

   

 

14:25 – 15:00

Live case V: Tricuspid Valve (Surgical)

L. Müller, A. Kocher

   
 

15:00 – 15:15

Functional tricuspid regurgitation – when to intervene?

G. Dreyfus

   
 
 

15:15 – 15:30

The role of  imaging in tricuspid interventions

F. Kreidel

   

 

15:30 – 15:45

Technique and outcomes of surgical tricuspid valve repair

F. van Praet

   

 

15:45 – 16:00

Surgical tricuspid valve replacement

R. Seitelberger

   

 

16:00 – 16:15

Transcatheter tricuspid valve repair – emerging evidence

F. Kreidel

   

 

16:15 – 16:30

Transcatheter tricuspid valve replacement – a feasable concept?

H. Figulla

   

 

 

16:30 – 16:45

The HeartTeam on Stage: Tricuspid repair – the ideal patient

A. Calafiore, G. Dreyfus, H. Figulla, F. Kreidel

 

 

 

 

 

17:15 – 17:30

Quantification of Functional Mitral Regurgitation

G. Goliasch

   
 

17:30 – 17:45

Transcatheter MV Interventions in FMR – Lessons learned in 2019

J. Hausleiter

   
 
 

17:45 – 18:00

Surgical MV  Repair in FMR – New Horizons

A. Calafiore

   

 

18:00 – 18:15

Novel Solutions for the Mitral Valve

M. Andreas

 

 

 

 

 

 
 

08:15 – 08:45

Personalized Medicine in Cardiovascular Disease

G. Dangas

 

 

 

 

 
 

09:00 – 09:20

Case presentations

M. Mach, P. Werner

   

 

09:00 – 09:20

Live case VI: Structural Intervention (TAVI + LAA-Verschluss)

M. Andreas, K. Neven

   

 

09:00 – 09:20

Live case VII: Mitral Repair with combined MAZE

N. Ad, S. Mahr

   
 

10:30 – 10:40

PFO – to close

B. Meier

   
 
 

10:40 – 10:50

PFO – or not to close

S. Greisenegger

   

 

 
 

10:50 – 11:05

Surgical LAA exclusion

S. Benussi

   

 

11:05 – 11:20

Interventional LAA closure 

U. Landmesser

   

 

11:20 – 11:35

Fire or Ice – Afib ablation in 2020

K.-H. Kuck

   

 

11:35 – 11:50

Surgical ablation in 2020

N. Ad

 

 

 

 

 
 

12:15 – 12:35

Live in the Box: Cinching the Mitral Apparatus to Treat FMR

M. Yildiz

   
 
 
 

12:35 – 12:55

First experiences with Allegra at AKH Vienna

P. Simon

   
 
 

12:55 – 13:15

Successful revascularization – The patient's perspective

C. Jensen

 

 

 

 

 
 

14:00 – 14:15

Update on non-invasive coronary imaging

C. Gebhard

   
 

14:15 – 14:30

Arterial grafting in CABG in 2020

M. Gaudino

   
 
 
 

14:30 – 14:45

ISCHEMIA trial – what to do in stable disease?

G. Hage

   
 
 
 

14:45 – 15:00

CTO trial update – what to do with the occluded vessel ?

J. Spratt

   

 

 

15:00 – 15:15

What we can learn from the TiCAB trial?

S. Sandner

   

 

15:15 – 15:30

Excel Trial revisited – consequences and lessons learned

T. Doenst

 

 
Skyline